Lila FeiseePrincipal at LF Life Sciences LLC
Lila Feisee is a 30-year veteran of the life sciences industry with 21+ years of experience at the Biotechnology Innovation Organization (BIO) in global health, regulatory, IP, market access policy, advocacy, problem-solving, and program development/implementation (2000-2021). She excels at writing persuasive comments, testimony and white papers pertaining to life sciences patents, trade, market access and regulatory issues.
While at BIO, Lila developed and implemented BIO's domestic and global intellectual property and regulatory priorities. Specifically, she developed and advocated BIO's IP positions in the America Invents Act and the Affordable Care Act. She also represented BIO's positions before the US government, the World Intellectual Property Organization (WIPO), World Trade Organization (WTO) and World Health Organization (WHO).
Additionally, she developed the organization’s global regulatory framework and represented BIO at the US FDA, the International Council on Harmonization (ICH) and Asia Pacific Economic Cooperation Regulatory Harmonization Steering Committee (APEC RHSC) on global regulatory issues. She helped BIO to build and maintain partnerships and coalitions with universities, academic institutions, NGOs, and investors and established BIO's long-standing conference for biopharmaceutical patent professionals; and BIO's University Industry Partnership Program.
Before joining BIO Lila was a patent examiner at the US Patent and Trademark Office (USPTO) examining biotechnology applications (1990-2000). While at the USPTO she was first a Supervisory Patent Examiner and then the Quality Administrator for the Biotechnology Patent Examining group 1600 with a focus on recombinant technologies. While at the USPTO, Lila was awarded the Department of Commerce’s Bronze Medal Award in 2000.
She started her career as a laboratory scientist in the National Institutes of Health (1986-1989) working on tumor antigens for testing, developing viable vectors for gene and cell therapy and recombinant monoclonal antibodies.
Lila graduated from George Washington University in Molecular biology, and the University of Virginia in Biology.
Lila is a native speaker of English, fluent in Farsi with reading fluency in Spanish.